• Inside the Recruitment and Data Management Challenges of the Million Veterans Program

    STAT | Veterans are donating their blood to the VA as part of one of the most ambitious projects ever undertaken to understand our DNA.

    Nov 12, 2015

  • WuXi NextCODE to Interpret Cancer Samples for UK 100,000 Genomes Project

    Bio-IT World News Brief | Genomics England, the state-owned company created to sequence 100,000 whole genomes of UK patients for health research, has announced that WuXi NextCODE will be its first Clinical Interpretation Partner in the field of cancer.

    Nov 12, 2015

  • DDN Launches Fast, Dense Storage Platform

    Bio-IT World | DataDirect Networks (DDN) announced a new storage platform this week: DDN SFA14K; the Texas Advanced Computing Center is the first announced deployment. The hybrid storage and hyper-converged platforms deliver fast, dense storage with more than 6 million IOPS and 60GB/sec in 4U with scalability to nearly 7PB of capacity in a single rack. 

    Nov 11, 2015

  • Cycle Offers Multiple Clouds in Single Dashboard, Awarded Patent

    Bio-IT World News Brief | Cycle Computing today announced a new version of its flagship product: CycleCloud. Version 5 is available immediately, and contains updates including a single dashboard for quickly and securely accessing and managing workloads on each of the world’s leading cloud service providers: AWS, Microsoft Azure, and Google Compute Engine.

    Nov 9, 2015

  • QIAGEN Releases GeneReader for Clinical Sequencing in Cancer

    Bio-IT World | Molecular diagnostics company QIAGEN has finally unveiled its DNA sequencer, the GeneReader, as a highly multiplexed clinical tool focused on somatic cancer, with full automation from sample preparation to variant interpretation.

    Nov 9, 2015

  • What's Going On in Craig Venter's Health Nucleus?

    STAT | Human Longevity, Craig Venter's latest company, has begun offering a strikingly comprehensive health scan featuring whole genome sequencing, microbiome analysis, and a series of imaging procedures. But many are skeptical any of this has real medical value.

    Nov 5, 2015

  • Verge Genomics Raises $4 Million with Help from Y Combinator

    TechCrunch | One of several biotechs recently backed by tech accelerator Y Combinator, Verge Genomics has closed a $4 million seed round to follow leads from its predictive algorithms for drug repurposing in neurological disease.

    Nov 4, 2015

  • MinION Sequencing Untangles RNA Transcripts in a Difficult Gene

    Bio-IT World | The Graveley lab at the University of Connecticut has demonstrated that the handheld MinION nanopore sequencer can distinguish between RNA isoforms in Dscam1, the most alternatively spliced gene known to science.

    Nov 3, 2015

  • IBM pumps up its hybrid-cloud muscle with Gravitant buy

    Computerworld | IBM bought Gravitant, a maker of brokerage software designed ease the purchase and management of software and services across mixed cloud platforms.

    Nov 3, 2015

  • Tute’s Knome-Powered Vision for an Integrated Genomics Vertical

    Bio-IT World  | Tute Genomics announced this morning that the company has acquired Knome, one of the earliest players in the consumer genomics space. The acquisition will further develop Tute’s genomics analysis pipeline in pursuit of an integrated genomics analysis product.

    Nov 2, 2015

  • Storify: Should Whole Genome Sequencing Be the Standard for Rare Disease?

    Bio-IT World | Elizabeth Worthey's comment that families affected by rare disease should push for whole genome sequencing has bioinformatics Twitter abuzz today, with a passionate and detailed debate about the best use of healthcare resources in the pursuit of a genetic diagnosis.

    Nov 2, 2015

  • End of the Line for Knome with Acquisition by Tute Genomics

    Xconomy | After eight years, more than $20 million raised, and an assortment of different business plans, Massachusetts genomics firm Knome has been acquired by tiny Tute Genomics of Utah.

    Nov 2, 2015

  • October News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including a CDC test of the Edico DRAGEN processor and new CRISPR partnerships.

    Oct 30, 2015

  • A Moore’s Law Mystery

    The Last Word On Nothing | Was Moore's Law originally developed as a marketing ploy for Intel?

    Oct 30, 2015

  • Direct Genomics' New Clinical Sequencer Revives a Forgotten DNA Technology

    Bio-IT World | At Direct Genomics in Shenzhen, He Jiankui is bringing back the sequencing technology of the defunct Helicos Biosciences to build a new DNA sequencer for the clinic, promising targeted diagnostic tests with minimal sample preparation and low input requirements.

    Oct 29, 2015

  • BGI Retools Complete Genomics Technology for Its New High-Throughput Benchtop Sequencer

    Bio-IT World | The BGISEQ-500, using a dramatically reengineered version of Complete Genomics' "DNA nanoball" sequencing, is designed to compete with Illumina's NextSeq instruments on both price and throughput — at least in the Chinese markets where it is being made available next year.

    Oct 28, 2015

  • TGAC Unleashes DRAGEN to Accelerate Genomics Workflows

    HPCwire | Accelerating genomics analysis remains one of the toughest challenges in life science research. All manner of optimizations are in use - disk streaming, op

    Oct 28, 2015

  • SwiftStack Announces Version 3.0

    Bio-IT World News Brief | Today at the OpenStack Summit in Tokyo, SwiftStack released version 3.0 of its software with new features that extend the benefits of object storage to enterprise applications.

    Oct 26, 2015

  • Bio-IT World Best Practices Call for Entries Open

    Bio-IT World Bio-IT World is accepting entries to the 2016 Bio-IT World Best Practices competition. For the past thirteen years, the Bio-IT World Best Practices Awards have highlighted outstanding examples of innovations and partnerships serving as powerful forces for change in the life sciences.

    Oct 26, 2015

  • Vertex and CRISPR Therapeutics Forge Deal on Gene Editing for Rare Disease

    Xconomy | In the latest major partnership around gene editing therapies based on CRISPR-Cas9 technology, Vertex is investing $105 million upfront in CRISPR Therapeutics, to support programs in cystic fibrosis and sickle cell disease, among other conditions.

    Oct 26, 2015